In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of NSAIDs. The NSAIDs are one of the mainstays of nonoperative treatment for OA and can provide pain relief for patients with mild disease. Oral NSAIDs are, however, associated with adverse events (e.g., peptic ulcer disease, acute kidney injury, increased cardiovascular risk, and bleeding) In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of braces and/or ambulatory aids. This recommendation is conditional because there may be exceptions to this recommendation, and the evidence supporting the recommendation is indirect and very low quality. The exceptions listed for the first recommendation above, including delay for personal reasons or other ongoing medical comorbidities, apply to this recommendation as well. Patients who are recovering from another lower limb surgery (e.g.,